European Journal of Clinical Oncology

Gastric cancer is related to high morbidity and mortality rates worldwide. Identifying individuals at high risk is vital for surveillance and prevention of gastric cancer. Endoscopic surveillance is additionally expected to profit individuals with a case history . Further large-scale, prospective studies are warranted to guage the cost-effectiveness and optimal time point for endoscopy during this population. To reduce the socioeconomic burden associated with gastric cancer, it's vital to spot and manage high risk group for gastric cancer. Atrophic gastritis (AG) and intestinal metaplasia (IM) are the foremost significant risk factors for gastric cancer. Therefore, the accurate selection of people with AG and IM could also be a key strategy for the prevention and/or early detection of gastric cancer. Laparoscopic gastrectomy has been widely accepted as a typical alternative for the treatment of early-stage gastric adenocarcinoma due to its favorable short-term outcomes. Laparoscopic gastrectomy appears to be promising; however, scientific evidence necessary to generalize this approach to a typical treatment for all relevant patients and care providers remains to be gathered.